Vascular Pharmaceuticals
Chapel Hill, US · Delaware corporation
Vascular Pharmaceuticals develops treatments for diabetic nephropathy, a kidney complication affecting people with Type 1 and Type 2 diabetes. Its lead drug candidate, VPI-2690B, is in Phase 2 clinical trials.
BiotechDigital Health
Founders & leadership
RS
Richard SheaExecutive
BL
Bonnie LaymanExecutive
DC
David ClemmonsNamed on SEC filing
Board
ES
Elizabeth StonerBoard director
RK
Richard KentBoard director
Reported raises · per SEC filings
Form D private placements$18.1M disclosed across 2 rounds · 2012–2015
▶$3MraisedJan 2016 · 6 investors · BiotechnologyRule 506(b)
▶$3MraisedJan 2016 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin RovinskiDirector
- Elizabeth StonerDirector
- David ClemmonsDirector
- Richard SheaExecutive Officer, Director
- Bonnie LaymanExecutive Officer
- Richard KentDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.1MraisedFeb 2015 · 6 investors · BiotechnologyRule 506(b)
▶$15.1MraisedFeb 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David ClemmonsDirector
- Richard SheaExecutive Officer, Director
- Richard KentDirector
- Elizabeth StonerDirector
- Bonnie LaymanExecutive Officer
- Offering amount
- $25.1M
- Amount sold
- $15.1M
- First sale
- Sep 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapMedscape15 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
UPMC9 shared keywordsUPMC operates a network of hospitals and health care facilities, offering medical services and specialties such as cancer care, cardiology, neurosciences, orthopaedics, and behavioral health. It provides patient tools for finding doctors, locating facilities by region, and accessing patient portals.
Companies competing with Vascular Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Vascular Pharmaceuticals do?
- Vascular Pharmaceuticals develops treatments for diabetic nephropathy, a kidney complication affecting people with Type 1 and Type 2 diabetes. Its lead drug candidate, VPI-2690B, is in Phase 2 clinical trials.
- How much funding has Vascular Pharmaceuticals raised?
- Vascular Pharmaceuticals has disclosed $18.1M raised across 2 rounds.
- Where is Vascular Pharmaceuticals headquartered?
- Vascular Pharmaceuticals is headquartered in Chapel Hill, US.